Grannus therapeutics
WebGRANNUS THERAPEUTICS, INC. is an Indiana Foreign For-Profit Corporation filed on December 18, 2024. The company's filing status is listed as Active and its File Number is 202412181445145 . The Registered Agent on file for this company is C T Corporation System and is located at 334 North Senate Avenue, Indianapolis, IN 46204. WebGrannus Therapeutics Inc. Street Address 1 Street Address 2; 7210 N. PENNSYLVANIA STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; INDIANAPOLIS: INDIANA: 46240: 3174146205: 3. Related Persons. Last Name First Name Middle Name; Foglesong: John: Street Address 1 Street Address 2;
Grannus therapeutics
Did you know?
WebGrannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms of HSP90. Use the CB Insights Platform to explore Grannus Therapeutics's full profile. WebGrannus LLC. Grannus LLC manufactures nitrogen fertilizers. The Company offers fertilizer products, as well as sells power as the byproduct. Grannus conducts business in the United States.
WebAbout us. Founded in 2024, Grannus Therapeutics is a pre-clinical stage biotechnology company, focused on the development of small molecule inhibitors for specific isoforms … WebGrannus Therapeutics a virtual startup developing novel Hsp90 inhibitors. Grannus is a University of Notre Dame biotechnology spinoff. Splice Bio (fka Proteo Design) Spain Private ProteoDesign is a biotech spin-out from Princeton University focused on personalized immuno-oncology therapies. The company is built on the pioneering discovery of a ...
WebSee Grannus Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Grannus Therapeutics's post-money valuation and revenue.
WebCompany profile page for Grannus LLC including stock price, company news, press releases, executives, board members, and contact information
WebGrannus Therapeutics. Location Indianapolis, Indiana, United States. Regions Great Lakes, Midwestern US. Gender Male. LinkedIn View on LinkedIn. John Foglesong is the Co-Founder, President, and Chief Executive Officer of Grannus Therapeutics. John Foglesong attended The Tuck School of Business at Dartmouth. diagram of puppies in the wombWebDec 1, 2024 · Information on valuation, funding, cap tables, investors, and executives for Grannus Therapeutics. Use the PitchBook Platform to explore the full profile. cinnamon roll flyerWebNational Directory of Integrative Health & Medicine Centers. The following listing of centers does not imply endorsement by FON Consulting. (Types of integrative services offered … diagram of rack and pinion steeringWeb1 • From 2009 to 2013, an annual average of 10.2% of adolescents aged 12–17 in Region III had first used alcohol within the year prior to being surveyed, whereas 5.2 % had first used cinnamon roll flourWebGrannus Therapeutics Biotechnology Research Indianapolis, IN NXT Capital Financial Services Chicago, IL Abilita Bio, Inc. Biotechnology Research San Diego, CA ... diagram of protein moleculeWebMar 22, 2024 · Grannus Therapeutics’ current funding runs through August 2024. Successfully completing a Phase I and Phase II STTR grant will enable them to exit by … diagram of prostatectomyWebGrannus Biosciences Limited develops and researches pharmaceutical products. The Company offers anti-inflammatory and anti-viral therapeutics and drug discovery … diagram of protein synthesis labeled